A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Trial details
- Registry ID
- NCT06830629
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 2 Study of MZE829 in Adults With APOL1 Kidney DiseaseNCT06830629 | Maze Therapeutics | Phase 2 | Recruiting | 2026-09Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |